Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Natural Killer Cell Therapies market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Natural Killer Cell Therapies market. Detailed analysis of key players, along with key growth strategies adopted by Natural Killer Cell Therapies industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Glycostem
Innate
Affimed
Fate Therapeutics
Fortress Biotech
Dragonfly Therapeutics
Nektar Therapeutics
Chipscreen Biosciences
NantWorks
Kiadis Pharma
Nkarta Therapeutics
By Type:
NK Cell Therapies
NK Cell Directed Antibodies
By End-User:
Cancer
Gastrointestinal Diseases
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Natural Killer Cell Therapies Market
-
1.3 Market Segment by Type
-
1.3.1 USA Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Therapies from 2016 to 2027
-
1.3.2 USA Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Directed Antibodies from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Natural Killer Cell Therapies Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.2 USA Natural Killer Cell Therapies Market Size and Growth Rate of Gastrointestinal Diseases from 2016 to 2027
-
1.4.3 USA Natural Killer Cell Therapies Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Natural Killer Cell Therapies Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Natural Killer Cell Therapies by Major Types
-
3.4.1 Market Size and Growth Rate of NK Cell Therapies
-
3.4.2 Market Size and Growth Rate of NK Cell Directed Antibodies
4 Segmentation of Natural Killer Cell Therapies Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Natural Killer Cell Therapies by Major End-Users
-
4.4.1 Market Size and Growth Rate of Natural Killer Cell Therapies in Cancer
-
4.4.2 Market Size and Growth Rate of Natural Killer Cell Therapies in Gastrointestinal Diseases
-
4.4.3 Market Size and Growth Rate of Natural Killer Cell Therapies in Others
5 Market Analysis by Regions
-
5.1 USA Natural Killer Cell Therapies Production Analysis by Regions
-
5.2 USA Natural Killer Cell Therapies Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Natural Killer Cell Therapies Landscape Analysis
-
6.1 West USA Natural Killer Cell Therapies Landscape Analysis by Major Types
-
6.2 West USA Natural Killer Cell Therapies Landscape Analysis by Major End-Users
7 South USA Natural Killer Cell Therapies Landscape Analysis
-
7.1 South USA Natural Killer Cell Therapies Landscape Analysis by Major Types
-
7.2 South USA Natural Killer Cell Therapies Landscape Analysis by Major End-Users
8 Middle West USA Natural Killer Cell Therapies Landscape Analysis
-
8.1 Middle West USA Natural Killer Cell Therapies Landscape Analysis by Major Types
-
8.2 Middle West USA Natural Killer Cell Therapies Landscape Analysis by Major End-Users
9 Northeast USA Natural Killer Cell Therapies Landscape Analysis
-
9.1 Northeast USA Natural Killer Cell Therapies Landscape Analysis by Major Types
-
9.2 Northeast USA Natural Killer Cell Therapies Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Glycostem
-
10.1.1 Glycostem Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Innate
-
10.2.1 Innate Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Affimed
-
10.3.1 Affimed Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Fate Therapeutics
-
10.4.1 Fate Therapeutics Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Fortress Biotech
-
10.5.1 Fortress Biotech Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Dragonfly Therapeutics
-
10.6.1 Dragonfly Therapeutics Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Nektar Therapeutics
-
10.7.1 Nektar Therapeutics Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Chipscreen Biosciences
-
10.8.1 Chipscreen Biosciences Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 NantWorks
-
10.9.1 NantWorks Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Kiadis Pharma
-
10.10.1 Kiadis Pharma Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Nkarta Therapeutics
-
10.11.1 Nkarta Therapeutics Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Therapies from 2016 to 2027
-
Figure USA Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Directed Antibodies from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Natural Killer Cell Therapies Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure USA Natural Killer Cell Therapies Market Size and Growth Rate of Gastrointestinal Diseases from 2016 to 2027
-
Figure USA Natural Killer Cell Therapies Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Natural Killer Cell Therapies Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Natural Killer Cell Therapies
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Natural Killer Cell Therapies by Different Types from 2016 to 2027
-
Table Consumption Share of Natural Killer Cell Therapies by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of NK Cell Therapies
-
Figure Market Size and Growth Rate of NK Cell Directed Antibodies
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Natural Killer Cell Therapies by Different End-Users from 2016 to 2027
-
Table Consumption Share of Natural Killer Cell Therapies by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Gastrointestinal Diseases
-
Figure Market Size and Growth Rate of Others
-
Table USA Natural Killer Cell Therapies Production by Regions
-
Table USA Natural Killer Cell Therapies Production Share by Regions
-
Figure USA Natural Killer Cell Therapies Production Share by Regions in 2016
-
Figure USA Natural Killer Cell Therapies Production Share by Regions in 2021
-
Figure USA Natural Killer Cell Therapies Production Share by Regions in 2027
-
Table USA Natural Killer Cell Therapies Consumption by Regions
-
Table USA Natural Killer Cell Therapies Consumption Share by Regions
-
Figure USA Natural Killer Cell Therapies Consumption Share by Regions in 2016
-
Figure USA Natural Killer Cell Therapies Consumption Share by Regions in 2021
-
Figure USA Natural Killer Cell Therapies Consumption Share by Regions in 2027
-
Table West USA Natural Killer Cell Therapies Consumption by Types from 2016 to 2027
-
Table West USA Natural Killer Cell Therapies Consumption Share by Types from 2016 to 2027
-
Figure West USA Natural Killer Cell Therapies Consumption Share by Types in 2016
-
Figure West USA Natural Killer Cell Therapies Consumption Share by Types in 2021
-
Figure West USA Natural Killer Cell Therapies Consumption Share by Types in 2027
-
Table West USA Natural Killer Cell Therapies Consumption by End-Users from 2016 to 2027
-
Table West USA Natural Killer Cell Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Natural Killer Cell Therapies Consumption Share by End-Users in 2016
-
Figure West USA Natural Killer Cell Therapies Consumption Share by End-Users in 2021
-
Figure West USA Natural Killer Cell Therapies Consumption Share by End-Users in 2027
-
Table South USA Natural Killer Cell Therapies Consumption by Types from 2016 to 2027
-
Table South USA Natural Killer Cell Therapies Consumption Share by Types from 2016 to 2027
-
Figure South USA Natural Killer Cell Therapies Consumption Share by Types in 2016
-
Figure South USA Natural Killer Cell Therapies Consumption Share by Types in 2021
-
Figure South USA Natural Killer Cell Therapies Consumption Share by Types in 2027
-
Table South USA Natural Killer Cell Therapies Consumption by End-Users from 2016 to 2027
-
Table South USA Natural Killer Cell Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Natural Killer Cell Therapies Consumption Share by End-Users in 2016
-
Figure South USA Natural Killer Cell Therapies Consumption Share by End-Users in 2021
-
Figure South USA Natural Killer Cell Therapies Consumption Share by End-Users in 2027
-
Table Middle West USA Natural Killer Cell Therapies Consumption by Types from 2016 to 2027
-
Table Middle West USA Natural Killer Cell Therapies Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Natural Killer Cell Therapies Consumption Share by Types in 2016
-
Figure Middle West USA Natural Killer Cell Therapies Consumption Share by Types in 2021
-
Figure Middle West USA Natural Killer Cell Therapies Consumption Share by Types in 2027
-
Table Middle West USA Natural Killer Cell Therapies Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Natural Killer Cell Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Natural Killer Cell Therapies Consumption Share by End-Users in 2016
-
Figure Middle West USA Natural Killer Cell Therapies Consumption Share by End-Users in 2021
-
Figure Middle West USA Natural Killer Cell Therapies Consumption Share by End-Users in 2027
-
Table Northeast USA Natural Killer Cell Therapies Consumption by Types from 2016 to 2027
-
Table Northeast USA Natural Killer Cell Therapies Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Natural Killer Cell Therapies Consumption Share by Types in 2016
-
Figure Northeast USA Natural Killer Cell Therapies Consumption Share by Types in 2021
-
Figure Northeast USA Natural Killer Cell Therapies Consumption Share by Types in 2027
-
Table Northeast USA Natural Killer Cell Therapies Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Natural Killer Cell Therapies Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Natural Killer Cell Therapies Consumption Share by End-Users in 2016
-
Figure Northeast USA Natural Killer Cell Therapies Consumption Share by End-Users in 2021
-
Figure Northeast USA Natural Killer Cell Therapies Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Glycostem
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glycostem
-
Figure Sales and Growth Rate Analysis of Glycostem
-
Figure Revenue and Market Share Analysis of Glycostem
-
Table Product and Service Introduction of Glycostem
-
Table Company Profile and Development Status of Innate
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate
-
Figure Sales and Growth Rate Analysis of Innate
-
Figure Revenue and Market Share Analysis of Innate
-
Table Product and Service Introduction of Innate
-
Table Company Profile and Development Status of Affimed
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed
-
Figure Sales and Growth Rate Analysis of Affimed
-
Figure Revenue and Market Share Analysis of Affimed
-
Table Product and Service Introduction of Affimed
-
Table Company Profile and Development Status of Fate Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fate Therapeutics
-
Figure Sales and Growth Rate Analysis of Fate Therapeutics
-
Figure Revenue and Market Share Analysis of Fate Therapeutics
-
Table Product and Service Introduction of Fate Therapeutics
-
Table Company Profile and Development Status of Fortress Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fortress Biotech
-
Figure Sales and Growth Rate Analysis of Fortress Biotech
-
Figure Revenue and Market Share Analysis of Fortress Biotech
-
Table Product and Service Introduction of Fortress Biotech
-
Table Company Profile and Development Status of Dragonfly Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dragonfly Therapeutics
-
Figure Sales and Growth Rate Analysis of Dragonfly Therapeutics
-
Figure Revenue and Market Share Analysis of Dragonfly Therapeutics
-
Table Product and Service Introduction of Dragonfly Therapeutics
-
Table Company Profile and Development Status of Nektar Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics
-
Figure Sales and Growth Rate Analysis of Nektar Therapeutics
-
Figure Revenue and Market Share Analysis of Nektar Therapeutics
-
Table Product and Service Introduction of Nektar Therapeutics
-
Table Company Profile and Development Status of Chipscreen Biosciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences
-
Figure Sales and Growth Rate Analysis of Chipscreen Biosciences
-
Figure Revenue and Market Share Analysis of Chipscreen Biosciences
-
Table Product and Service Introduction of Chipscreen Biosciences
-
Table Company Profile and Development Status of NantWorks
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantWorks
-
Figure Sales and Growth Rate Analysis of NantWorks
-
Figure Revenue and Market Share Analysis of NantWorks
-
Table Product and Service Introduction of NantWorks
-
Table Company Profile and Development Status of Kiadis Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kiadis Pharma
-
Figure Sales and Growth Rate Analysis of Kiadis Pharma
-
Figure Revenue and Market Share Analysis of Kiadis Pharma
-
Table Product and Service Introduction of Kiadis Pharma
-
Table Company Profile and Development Status of Nkarta Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nkarta Therapeutics
-
Figure Sales and Growth Rate Analysis of Nkarta Therapeutics
-
Figure Revenue and Market Share Analysis of Nkarta Therapeutics
-
Table Product and Service Introduction of Nkarta Therapeutics
-
